BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2444916)

  • 1. Saliva, xerostomia and salivary substitutes.
    Brastings ED
    Pa Dent J (Harrisb); 1987; 54(5):23-4. PubMed ID: 2444916
    [No Abstract]   [Full Text] [Related]  

  • 2. [Saliva substitutes].
    Perejoan Rouch M
    Rev Esp Estomatol; 1985; 33(5):327-32. PubMed ID: 3870005
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs in dentistry. Managing xerostomia.
    Ciancio SG
    Dent Manage; 1987 Dec; 27(12):59-60. PubMed ID: 3482555
    [No Abstract]   [Full Text] [Related]  

  • 4. [Xerostomia. II. Therapeutic possibilities].
    Vissink A; Panders AK; s'-Gravenmade EJ; Vermey A
    Ned Tijdschr Geneeskd; 1985 Oct; 129(43):2054-7. PubMed ID: 3908942
    [No Abstract]   [Full Text] [Related]  

  • 5. Saliva: 3. Xerostomia--aetiology and management.
    Levine RS
    Dent Update; 1989 Jun; 16(5):197-201. PubMed ID: 2636197
    [No Abstract]   [Full Text] [Related]  

  • 6. [Saliva substitutes].
    Bottenberg P; Kochanska B
    Rev Belge Med Dent (1984); 2006; 61(3):180-7. PubMed ID: 17408139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xerostomia.
    Lancet; 1989 Apr; 1(8643):884. PubMed ID: 2564957
    [No Abstract]   [Full Text] [Related]  

  • 8. Replacement therapy in a dry mouth patient: a review.
    Edmonds EJ; Shannon IL
    J Hosp Dent Pract; 1980; 14(1):30-4. PubMed ID: 6765268
    [No Abstract]   [Full Text] [Related]  

  • 9. Artificial saliva in the management of patients suffering from xerostomia.
    s-Gravenmade EJ; Vissink A; Panders AK; Vermey A
    Gerodontology; 1984; 3(4):243-50. PubMed ID: 6598991
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind crossover trial of CMC- and mucin-containing saliva substitutes.
    Visch LL; Gravenmade EJ; Schaub RM; Van Putten WL; Vissink A
    Int J Oral Maxillofac Surg; 1986 Aug; 15(4):395-400. PubMed ID: 3091718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of salivary substitutes versus a natural sialogogue (citric acid) in patients complaining of dry mouth as an adverse drug reaction: a clinical, randomized controlled study.
    Femiano F; Rullo R; di Spirito F; Lanza A; Festa VM; Cirillo N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):e15-20. PubMed ID: 21507689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An agent for mouth dryness].
    Söderling E; Le Bell Y
    Suom Hammaslaakarilehti; 1986 Mar; 33(5):298-304. PubMed ID: 3462870
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of artificial saliva developed for the treatment of postradiation xerostomia. 1. Preliminary results].
    Macan D; Rukavina K; Virag M; Krajina Z
    Chir Maxillofac Plast; 1986; 16(3):123-9. PubMed ID: 3477413
    [No Abstract]   [Full Text] [Related]  

  • 14. Managing complications of radiation therapy in head and neck cancer patients: Part I. Management of xerostomia.
    Ngeow WC; Chai WL; Rahman RA; Ramli R
    Singapore Dent J; 2006 Dec; 28(1):1-3. PubMed ID: 17378333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xerostomia: diagnosis and treatment planning considerations.
    Glass BJ; Van Dis ML; Langlais RP; Miles DA
    Oral Surg Oral Med Oral Pathol; 1984 Aug; 58(2):248-52. PubMed ID: 6592521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xerostomia: the "invisible" oral health condition.
    Friedman PK; Isfeld D
    J Mass Dent Soc; 2008; 57(3):42-4. PubMed ID: 19146117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and treatment of salivary induced conditions.
    Sreebny LM
    Int Dent J; 1989 Sep; 39(3):197-204. PubMed ID: 2676866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial saliva products and drugs to treat xerostomia.
    Wynn RL; Meiller TF
    Gen Dent; 2000; 48(6):630-6. PubMed ID: 12004654
    [No Abstract]   [Full Text] [Related]  

  • 19. A critical assessment of oral lubricants in patients with xerostomia.
    Wiesenfeld D; Stewart AM; Mason DK
    Br Dent J; 1983 Sep; 155(5):155-7. PubMed ID: 6587862
    [No Abstract]   [Full Text] [Related]  

  • 20. Removable prosthodontic therapy and xerostomia. Treatment considerations.
    Massad JJ; Cagna DR
    Dent Today; 2002 Jun; 21(6):80-2, 84, 86-7. PubMed ID: 12073484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.